You are here: All Products  > CASI Granted Breakthrough Status in China for CD19 CAR-T Therapy

CASI Granted Breakthrough Status in China for CD19 CAR-T Therapy

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products